ev3 Inc. (EVVV) said that a voluntary Class I recall of the TrailBlazer Support Catheter was completed in December 2009, and all affected units are in the company's possession. However, no other ev3 devices were involved in this action.
On January 5, 2010, the U.S. Food & Drug Administration disclosed the voluntary recall of the TrailBlazer Support Catheter. The voluntary recall was initiated in November 2009 after the company received reports of cracking on the device near the marker band from physicians during the initial limited market release of the device in the U.S. The action was reported to the FDA, and 28 affected accounts were notified by physician letter. The recall of approximately 350 individual catheters was completed and a final closure report was sent to the FDA in December 2009.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.